Curcumin exhibits anti-inflammatory and anti-tumor activities. Although its functional mechanism has not been elucidated so far, numerous studies have shown that curcumin induces apoptosis in cancer cells. In the present study, we show that subtoxic concentrations of curcumin sensitize human renal cancer cells to the tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis. This apoptosis induced by the combination of curcumin and TRAIL is not interrupted by Bcl-2 overexpression. We found that treatment with curcumin significantly induces DR5 expression both at its mRNA and protein levels, accompanying the generation of the reactive oxygen species (ROS). Not only the pretreatment with NAC but also the ectopic expression of peroxiredoxin II (Prx II), an anti-oxidative protein, dramatically inhibited the apoptosis induced by curcumin and TRAIL in combination, blocking of curcumin-mediated DR5 up-regulation. Taken together, the present study demonstrates that curcumin enhances TRAIL-induced apoptosis by ROS-mediated DR5 up-regulation.
Introduction
Curcumin is a major component of the Curcuma species, which is commonly used as a yellow coloring and flavoring agent in foods. Recently, several studies have shown that curcumin possesses anti-proliferative activity against tumor cells in vitro (1) .
Moreover, curcumin exhibits anti-carcinogenic activity in vivo, as indicated by its inhibition of tumor initiation induced by various carcinogens or phorbol esters (2-4).
Although curcumin-induced cancer chemopreventive activity have been repeatedly reported in various cancer cell lines including skin, oral, intestinal, breast and colon cancer cells (5) (6) (7) (8) , the mechanisms underlying the diverse effects of curcumin on cancer cells are not fully understood.
Recently, it has been reported that curcumin treatment results in the production of reactive oxygen species (ROS) (9, 10). ROS is involved in the initiation and progression of a variety of human diseases (11), including renal ischemia/reperfusion injury and in toxicities associated with chemical exposure. The kidney or kidney-derived cells have an increased susceptibility towards agents generating ROS in terms of apoptogenecity and proliferation, and ROS play an important role in the pathogenesis of a variety of renal diseases (12). Renal cell carcinoma remains one of the most drug-resistant malignancies in humans and is a frequent cause of cancer mortality (13), necessitating the development of novel therapeutic strategies against this type of cancer. In this study, we investigated the relationship between the curcumin-induced oxidative response and toxicity in renal carcinoma cells, human renal Caki cells.
Tumor necrosis factor (TNF) α-related apoptosis-inducing ligand (TRAIL), also known as Apo2L, is a member of the TNF family and can induce apoptotic cell death in a variety of cancer cell types (14-16). TRAIL binds to four different types of 
DNA Fragmentation Assay
After treatment with curcumin, TRAIL, and combination of TRAIL and curcumin for 24 h, Caki cells were lysed in a buffer containing 10 mM Tris (pH 7.4), 150 mM NaCl, 5 mM EDTA, and 0.5% Triton X-100 for 30 min on ice. Lysates were vortexed and cleared by centrifugation at 10,000 g for 20 min. Fragmented DNA in the supernatant was extracted with an equal volume of neutral phenol : chloroform : isoamyl alcohol mixture (25 : 24 : 1) and analyzed electrophoretically on 2% agarose gels containing 0.1 µg/ml of ethidium bromide.
Asp-Glu-Val-Asp-ase (DEVDase) Activity Assay
To evaluate DEVDase activity, cell lysates were prepared after their respective treatment with TRAIL or curcumin. Assays were performed in 96-well microtiter plates by incubating 20 µg of cell lysates in 100 µl of reaction buffer (1% NP-40, 20 mM TrisHCl, pH 7.5, 137 mM NaCl, 10% glycerol) containing the caspases substrate [Asp-GluVal-Asp-chromophore-p-nitroanilide (DVAD-pNA)] at 5 µM. Lysates were incubated at 37°C for 2 h. Thereafter, the absorbance at 405 nm was measured with a 
Measurement of Reactive Oxygen Species
The intracellular accumulation of ROS was determined using the fluorescent probes DHE and H 2 DCFDA. DHE preferentially measures O -· 2 (24). H 2 DCFDA was commonly used to measure H 2 O 2 (25). Cells were collected by centrifugation, 1 h prior to treatment with the cytotoxic agents, resuspended in DMEM medium without red phenol, and loaded with either 5 µM H 2 DCFDA or 2 µM DHE. The fluorescence was measured at the desired time intervals by flow cytometry or confocal microscopy. Control cells were subjected to the same manipulation, except for treatment with the curcumin.
Plasmids, Transfections, and Luciferase Gene Assays
The human DR5 promoter (pDR5/SacI plasmid)-containing plasmids have been described previously (26). In brief, cells were plated onto 6-well plates at a density of 
RNA Isolation and Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
To determine whether the potential sensitizing effects of curcumin to TRAIL-mediated 
Results

Curcumin sensitizes TRAIL-mediated apoptosis
To investigate the effect of curcumin on TRAIL-mediated apoptosis, human renal cancer cell line Caki cells were treated with curcumin alone (30 µM), TRAIL alone (100 ng/ml), or combination of curcumin and TRAIL. Three established criteria were subsequently used to assess apoptosis in our system. First, apoptosis in Caki cells was (Fig. 1B) . In addition, we analyzed whether cotreatment with curcumin and TRAIL gave rise to the activation of caspases, a key executioner of apoptosis.
Cotreatment of Caki cells with curcumin and TRAIL strongly stimulated DEVDase activity ( Fig. 1C ) and led to a reduction of the protein levels of 32-kDa precursor together with a concomitant cleavage of phospholipase C-γ1 (PLC-γ1), a substrate protein of caspases (Fig. 1D ). Taken together, these results indicate that treatment with curcumin sensitizes Caki cells to TRAIL-mediated apoptosis.
Curcumin up-regulates DR5 in various cancer cells
It is well known that TRAIL interacts with death receptors (DR4 and DR5) to trigger (Fig. 6A) . Expression of Prx II significantly reduced DR5 protein levels and DR5 promoter activity after treatment with curcumin ( Fig. 6B ). While treatment with curcumin plus TRAIL induced significant apoptosis in Caki/vector cells, the apoptotic characteristics, such as cell shrinkage, apoptotic bodies, and detachment from the plates, were much less frequently observed in Caki/Prx II cells treated with curcumin plus TRAIL (Fig. 6C) . Moreover, ectopic expression of Prx II significantly inhibited reduction of the protein levels of 32-kDa precursor and cleavage of PLC-γ1, a substrate protein of caspases (Fig. 6D ). In parallel with the degradation of caspase 3, after 24 h exposure to curcumin plus TRAIL, Caki/vector cells exhibited a significant increase in DEVDase activity, while only a half level of the activity was observed in Caki/Prx II cells (Fig. 6E ). Taken together, Prx II overepxression protects Caki cells against curcumin plus TRAIL-induced apoptosis.
Apoptosis induced by curcumin plus TRAIL is not blocked by Bcl-2-overexpression
Overexpression of Bcl-2 is known to inhibit chemotherapy-induced apoptosis (33). To determine the effect of co-treatment with curcumin and TRAIL on the viability of Bcl- In addition, ectopic expression of Bcl-2 did not inhibit reduction of the protein levels of 32-kDa precursor and cleavage of PLC-γ1 (Fig. 7C) . After 24 h exposure to curcumin plus TRAIL, both Caki/vector and Caki/Bcl-2 cells exhibited a similar increased DEVDase activity (Fig. 7C ). These data suggest that the combined treatment with curcumin and TRAIL may effectively induce apoptotic cell death in Bcl-2-overexpressing cancer cells, which are relatively resistant to chemotherapy. We demonstrate in the present study that subtoxic concentrations of the curcumin However in this study, we provide a novel mechanism that up-regulation of DR5 is essential for curcumin plus TRAIL-induced apoptosis.
Recently it has been suggested that oxidative stress plays a role as a common mediator of apoptosis (41). We and other groups reported that curcumin generates representative study is shown; two additional experiments yielded similar results.
DEVDase activity was determined as described in Figure 1C . 
